Vitamin-based therapy for DM: ATRA (a derivative of Vitamin-A) increases the expression of a positive regulator of insulin transcription, NeuroD1 via down regulation of its target gene, 3/September/2014, 05.08 am

Insights into the development of cardiac-safe analgesics: Snail/SNAI1 inhibits inflammatory pain stimuli via up regulation of aldehyde dehydrogenase 2, 2/September/2014, 13.03
September 2, 2014
Natural product-based therapy for Cancer: Resveratrol increases the expression of tumor suppressor LKB1 via down regulation of its target gene, 3/September/2014, 05.24 am
September 2, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Vitamin-based therapy for DM: ATRA (a derivative of Vitamin-A) increases the expression of a positive regulator of insulin transcription, NeuroD1 via down regulation of its target gene, 3/September/2014, 05.08 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance:  It has been known for years that ATRA  inhibits insulin resistance. However, the mechanistic basis remains far from clear.  This study suggests, for the first time, that  ATRA, by increasing the expression of its target gene, it may decrease the expression of a number of stress responsive proteins. Thereby, it may increase the expression of an activator of insulin transcription, NeuroD1.  Given this, physicians may consider prescribing “ATRA” to treat DM.

Comments are closed.